Multimer Detection System-Oligomerized Amyloid Beta (MDS-OA<i>β</i>): A Plasma-Based Biomarker Differentiates Alzheimer's Disease from Other Etiologies of Dementia.

There was only marginally significant difference when MDS-OA β patient/control (PT/C) ratio was compared across different age groups (≤59, 60-69, 70-79, and ≥80 years old) among four etiologic diagnosis ( p = 0.07, Table 1 ), indicating MDS-OA β level does not significantly vary based on age groups but more significantly on etiologic cause of cognitive impairment and dementia. 4.

also in 5,076 other papers